-31.1% · 90d
$8.59
+0.30 (+3.62%)
News
(1)April 2026
NEOGENOMICS INC — DEF 14A Filing
NEONEOGENOMICS INC
# 🧾 What This Document Is This is a **DEF 14A, or "Proxy Statement."** Think of it as an invitation and a handbook for Neogenomics' upcoming annual shareholder meeting. It's where the company formally asks shareholders to vote on key issues, like electing the board of directors and approving execut
Read summaryView on SEC EDGAR
Peers in Diagnostics & Research
TMO#1
Thermo Fisher Scientific Inc.
$185.98B-0.60%
DHR#2
Danaher Corporation
$136.58B-1.63%
IDXX#3
IDEXX Laboratories, Inc.
$46.56B-1.20%
A#4
Agilent Technologies, Inc.
$32.61B-1.31%
WAT#5
Waters Corporation
$31.16B-0.28%
NTRA#6
Natera, Inc.
$28.77B-3.71%
IQV#7
IQVIA Holdings Inc.
$28.37B-2.06%
MTD#8
Mettler-Toledo International Inc.
$27.03B+0.93%
LH#9
Labcorp Holdings Inc.
$22.52B-0.53%
DGX#10
Quest Diagnostics Incorporated
$21.90B-0.50%